Cuorips Inc. (4894.T)
JPY 4585.0
(-4.18%)
JPY 4585.0
(-4.18%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.04 Million JPY | -77.99% |
| 2022 | 4.73 Million JPY | 47280.0% |
| 2021 | 10 Thousand JPY | -41.18% |
| 2020 | 17 Thousand JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 13.25 Million JPY | 1171.05% |
| 2023 Q2 | 3.83 Million JPY | -28.17% |
| 2023 FY | 1.04 Million JPY | -77.99% |
| 2023 Q4 | 1.04 Million JPY | -74.45% |
| 2023 Q3 | 4.08 Million JPY | 6.36% |
| 2023 Q1 | 5.34 Million JPY | 12.77% |
| 2022 FY | 4.73 Million JPY | 47280.0% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q4 | 4.73 Million JPY | 0.0% |
| 2021 FY | 10 Thousand JPY | -41.18% |
| 2020 FY | 17 Thousand JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 99.847% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | 94.183% |
| GNI Group Ltd. | 2.33 Billion JPY | 99.955% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 99.953% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 98.454% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 99.907% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 98.993% |
| AnGes, Inc. | 1.61 Billion JPY | 99.935% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 98.591% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 99.964% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 99.676% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -466.848% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 99.256% |
| CanBas Co., Ltd. | 728 Thousand JPY | -43.269% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 98.813% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 99.295% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 98.373% |
| Kidswell Bio Corporation | 875.65 Million JPY | 99.881% |
| PeptiDream Inc. | 2.4 Billion JPY | 99.957% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | 80.475% |
| Ribomic Inc. | 2.27 Million JPY | 54.134% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -104299900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | 97.103% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | 96.403% |
| CellSource Co., Ltd. | 305.92 Million JPY | 99.659% |
| FunPep Company Limited | 25.54 Million JPY | 95.916% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 99.714% |
| Stella Pharma Corporation | 1.11 Billion JPY | 99.907% |
| TMS Co., Ltd. | 50.02 Million JPY | 97.915% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | 95.01% |
| K Pharma,Inc. | 10.79 Million JPY | 90.337% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.991% |
| ReproCELL Incorporated | 248.14 Million JPY | 99.58% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 99.769% |
| StemCell Institute Inc. | 42.26 Million JPY | 97.532% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 99.544% |
| CellSeed Inc. | 46.19 Million JPY | 97.742% |